NYXH Nyxoah S.A.Stock Price & Overview
$4.82-0.08 (-1.63%)9:50 AM 12/05/23
NASDAQ | $USD | Delayed
People Also Follow
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.